US 9957251
Heterocyclic compound
granted A61KA61K31/4439A61K31/444
Quick answer
US patent 9957251 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/4439, A61K31/444, A61K31/4545, A61K31/4704